Please type a search term (at least two characters)
News
MetroMRT contributes to clinical trial of cancer treatment
Results of EMRP project MetroMRT (HLT11) implemented in first clinical trial with image-based dosimetry
One of the calibration protocols developed with funding from EMRP project 'Metrology for molecular radiotherapy' MetroMRT and the UK National Measurement and Regulation Office (NMRO) is being used for implementation of dosimetry in a new clinical trial - the first to use image-based dosimetry.
The Cancer Research UK funded clinical trial, SEL-I-METRY, is investigating the potential use of the drug selumetinib to resensitise thyroid cancers which have stopped responding to radioiodine therapy. Patients are expected to be recruited in January 2016.
Molecular radiotherapy (MRT) has the potential to become a valuable tool in the treatment of cancer. However, widespread MRT use is being hampered by a reluctance to adopt individual patient-tailored dosimetry, which is perceived to be difficult and resource intensive.
The MetroMRT project 'Metrology for molecular radiotherapy' developed the metrology needed to support routine use of individual MRT patient dosimetry, and working with the MRT community to develop standard procedures incorporating both calibration and verification.
The project partners publicised the metrological developments for electronic brachytherapy and were able to contribute to several standards more
EMPIR project established clinical procedures that allow use of traceable methodologies for molecular radiotherapy across Europe more
A small collaborative project aimed at extending knowledge in the field of eye tonometers has increased its impact more
Improving large-scale dimensional measurements for manufacturing more
From 2012 to 2016 the IEEE published standards for high-frequency waveguides. EMPIR NeWITT project supports their uptake more